Cargando…
An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate
Organ cultures are practical tools to investigate regenerative strategies for the intervertebral disc. However, most existing organ culture systems induce severe tissue degradation with only limited representation of the in vivo processes. The objective of this study was to develop a space- and cost...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085673/ https://www.ncbi.nlm.nih.gov/pubmed/27689996 http://dx.doi.org/10.3390/ijms17101640 |
_version_ | 1782463618079522816 |
---|---|
author | Krupkova, Olga Hlavna, Marian Amir Tahmasseb, Julie Zvick, Joel Kunz, Dominik Ito, Keita Ferguson, Stephen J. Wuertz-Kozak, Karin |
author_facet | Krupkova, Olga Hlavna, Marian Amir Tahmasseb, Julie Zvick, Joel Kunz, Dominik Ito, Keita Ferguson, Stephen J. Wuertz-Kozak, Karin |
author_sort | Krupkova, Olga |
collection | PubMed |
description | Organ cultures are practical tools to investigate regenerative strategies for the intervertebral disc. However, most existing organ culture systems induce severe tissue degradation with only limited representation of the in vivo processes. The objective of this study was to develop a space- and cost-efficient tissue culture model, which represents degenerative processes of the nucleus pulposus (NP). Intact bovine NPs were cultured in a previously developed system using Dyneema jackets. Degenerative changes in the NP tissue were induced either by the direct injection of chondroitinase ABC (1–20 U/mL) or by the diffusion of interleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α) (both 100 ng/mL) from the culture media. Extracellular matrix composition (collagens, proteoglycans, water, and DNA) and the expression of inflammatory and catabolic genes were analyzed. The anti-inflammatory and anti-catabolic compound epigallocatechin 3-gallate (EGCG, 10 µM) was employed to assess the relevance of the degenerative NP model. Although a single injection of chondroitinase ABC reduced the proteoglycan content in the NPs, it did not activate cellular responses. On the other hand, IL-1β and TNF-α significantly increased the mRNA expression of inflammatory mediators IL-6, IL-8, inducible nitric oxide synthase (iNOS), prostaglandin-endoperoxide synthase 2 (PTGS2) and matrix metalloproteinases (MMP1, MMP3, and MMP13). The cytokine-induced gene expression in the NPs was ameliorated with EGCG. This study provides a proof of concept that inflammatory NP cultures, with appropriate containment, can be useful for the discovery and evaluation of molecular therapeutic strategies against early degenerative disc disease. |
format | Online Article Text |
id | pubmed-5085673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-50856732016-11-01 An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate Krupkova, Olga Hlavna, Marian Amir Tahmasseb, Julie Zvick, Joel Kunz, Dominik Ito, Keita Ferguson, Stephen J. Wuertz-Kozak, Karin Int J Mol Sci Article Organ cultures are practical tools to investigate regenerative strategies for the intervertebral disc. However, most existing organ culture systems induce severe tissue degradation with only limited representation of the in vivo processes. The objective of this study was to develop a space- and cost-efficient tissue culture model, which represents degenerative processes of the nucleus pulposus (NP). Intact bovine NPs were cultured in a previously developed system using Dyneema jackets. Degenerative changes in the NP tissue were induced either by the direct injection of chondroitinase ABC (1–20 U/mL) or by the diffusion of interleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α) (both 100 ng/mL) from the culture media. Extracellular matrix composition (collagens, proteoglycans, water, and DNA) and the expression of inflammatory and catabolic genes were analyzed. The anti-inflammatory and anti-catabolic compound epigallocatechin 3-gallate (EGCG, 10 µM) was employed to assess the relevance of the degenerative NP model. Although a single injection of chondroitinase ABC reduced the proteoglycan content in the NPs, it did not activate cellular responses. On the other hand, IL-1β and TNF-α significantly increased the mRNA expression of inflammatory mediators IL-6, IL-8, inducible nitric oxide synthase (iNOS), prostaglandin-endoperoxide synthase 2 (PTGS2) and matrix metalloproteinases (MMP1, MMP3, and MMP13). The cytokine-induced gene expression in the NPs was ameliorated with EGCG. This study provides a proof of concept that inflammatory NP cultures, with appropriate containment, can be useful for the discovery and evaluation of molecular therapeutic strategies against early degenerative disc disease. MDPI 2016-09-27 /pmc/articles/PMC5085673/ /pubmed/27689996 http://dx.doi.org/10.3390/ijms17101640 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Krupkova, Olga Hlavna, Marian Amir Tahmasseb, Julie Zvick, Joel Kunz, Dominik Ito, Keita Ferguson, Stephen J. Wuertz-Kozak, Karin An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate |
title | An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate |
title_full | An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate |
title_fullStr | An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate |
title_full_unstemmed | An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate |
title_short | An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate |
title_sort | inflammatory nucleus pulposus tissue culture model to test molecular regenerative therapies: validation with epigallocatechin 3-gallate |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085673/ https://www.ncbi.nlm.nih.gov/pubmed/27689996 http://dx.doi.org/10.3390/ijms17101640 |
work_keys_str_mv | AT krupkovaolga aninflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT hlavnamarian aninflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT amirtahmassebjulie aninflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT zvickjoel aninflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT kunzdominik aninflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT itokeita aninflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT fergusonstephenj aninflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT wuertzkozakkarin aninflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT krupkovaolga inflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT hlavnamarian inflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT amirtahmassebjulie inflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT zvickjoel inflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT kunzdominik inflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT itokeita inflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT fergusonstephenj inflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate AT wuertzkozakkarin inflammatorynucleuspulposustissueculturemodeltotestmolecularregenerativetherapiesvalidationwithepigallocatechin3gallate |